In terms of market performance, Standard BioTools Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $3.04 on 04/09/24, while the lowest value was $1.21 on 08/01/24.
52-week price history of LAB Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Standard BioTools Inc’s current trading price is -43.09% away from its 52-week high, while its distance from the 52-week low is 42.98%. The stock’s price range for this period has remained between $1.21 and $3.04. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.91 million for the day, which was noticeably lower compared to the shares’ average daily volume of 2.06 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Standard BioTools Inc (LAB) has experienced a quarterly decline of -26.38% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 642.09M and boasts a workforce of 539 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.9653, with a change in price of -0.7500. Similarly, Standard BioTools Inc recorded 2,603,848 in trading volume during the last 100 days, posting a change of -30.24%.
LAB Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LAB stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.06.
LAB Stock Stochastic Average
As of today, the raw stochastic average of Standard BioTools Inc over the last 50 days is at 16.13%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 15.38%. Further, the company’s Stochastic %K and %D values for the last 20 days were 33.33% and 47.67%, respectively.
LAB Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price decrease of -21.72%. However, over the past six months, we’ve seen a stronger performance of -26.69%. The price of LAB leaped by -5.46% over the last 30 days. And in the last five days, it has fallen by -3.89%.
